Corbus Pharmaceuticals Holdings, Inc.
CRBP
$9.05
-$0.58-6.02%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/18/2026
-
Globe Newswire
3/14/2026
-
Ticker Report
3/13/2026
-
Tickeron - Stocks
3/12/2026
-
MarketBeat
3/11/2026
-
Zacks Investment Research
3/11/2026
-
MarketBeat
3/10/2026
-
MarketBeat
3/10/2026
-
Tickeron - Stocks
3/10/2026
-
Tickeron - Stocks
3/9/2026
-
MarketBeat
3/9/2026
-
Globe Newswire
Corbus Pharmaceuticals Holdings (CRBP, $8.37) Aroon Indicator entered a Downtrend on March 02, 2026.
3/3/2026
-
Tickeron - Stocks
3/3/2026
-
MarketBeat
2/28/2026
-
Tickeron - Technical Analysis
2/27/2026
-
Tickeron - Stocks
2/27/2026
-
Tickeron - Stocks
2/26/2026
-
MarketBeat
2/26/2026
-
Tickeron - Stocks
2/26/2026
-
Tickeron - Stocks
2/24/2026
-
Tickeron - Stocks
2/22/2026
-
Ticker Report
2/19/2026
-
MarketBeat
2/17/2026
-
MarketBeat
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
2/12/2026
-
Globe Newswire
2/7/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 9, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 963 0100
Address
500 River Ridge Drive
Norwood, MA 02062
Norwood, MA 02062
Country
Year Founded
Business Description
Sector
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that...
more